Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
2 Introduction/background: history of incretin mimetics medications GIP was the first incretin isolated and characterized in the 1970s though most modern therapies focus on GLP-1 [17]
Some patients use HSA or FSA funds when eligible, but you should confirm with your benefits administrator
Who It Is For Patients with stubborn visceral fat that resists diet and exercise Men and women experiencing metabolic slowdown associated with aging Patients with insulin resistance or metabolic syndrome who want to improve metabolic markers Anyone seeking meaningful body recomposition not just weight loss, but shifting the ratio of fat to lean mass Patients who have plateaued on a weight loss program and need a metabolic reset What to Expect Weeks 1-4: Improved energy and exercise tolerance as mitochondrial function improves
On a 100-unit syringe, the major numbered lines appear at 10, 20, 30, 40, 50, 60, 70, 80, 90, and 100
Visceral Fat Loss: High efficacy in targeting "stubborn" belly fat, which is the most metabolically active and dangerous type of fat
US$ 29.96
US$ 21.84
US$ 29.52
US$ 21.86
US$ 29.77
